Search past winners/finalists


  • MESA logo

Perrigo Company

 

Gold Stevie Award Winner 2012, Click to Enter The 2013 American Business Awards

Company: Perrigo Company, Allegan, MI
Company Description: Founded in 1887, Perrigo is a major multinational pharmaceutical company with more than 6,000 employees and production facilities in the U.S., Israel, United Kingdom and Mexico. Perrigo is among the world’s larger manufacturers of OTC pharmaceuticals. Every product we manufacture meets or exceeds the stringent standards set by the U.S. Food and Drug Administration for branded and store brand OTC products. Perrigo is also a leading global manufacturer of generic topical Rx drugs, nutritional products, and active pharmaceutical ingredients.
Nomination Category: Management Categories
Nomination Sub Category: Executive of the Year - Pharmaceuticals

Nomination Title: Joseph C. Papa, CEO

Perrigo had a great year with 50 new products, strong brand development "GoodSense" and generic pharmaceuticals. Perrigo saves consumers over $5 billion annually and continually strives to make quality healthcare more affordable."

Said Joseph Papa "This is my fourth year at Perrigo and I've been honored to lead this dedicated team as we have achieved record results." I outlined our goal for the businesses.

• First, expand into adjacent product categories;

o 2011, Perrigo acquired Paddock Laboratories.: The resulting portfolio for the Rx division focuses on topical formulations such as creams, ointments, gels, lotions, solutions, suspensions, suppositories, enemas, nasal sprays and foams.

o Perrigo Announces the First Store Brand Launch of the Generic Version of Rogaine® 5% Foam. "This is another example of Perrigo's significant investment and commitment to bringing new store brand products to the market

o “Perrigo announced an acquisition of, a bolt-on company in the diabetes space that’s going to help us to continue to improve our offering in the store brand Private Label space for diabetes”

• Second, take our store brand OTC healthcare business model into new geographic markets;

o Perrigo is the only store brand Private Label manufacturer of infant formula in the United States
o In 2011, Perrigo did do two deals in the China market. “We already have been shipping some product, but we think this will dramatically increase the opportunities for us in the future”

• Third, enter into strategic partnerships to broaden our product portfolio.

o “It is not our intent to make every raw material that we have, but clearly it puts us in a very good negotiating position where we know and understand how much these raw materials should cost us starting at these raw materials and ending up with a finished active ingredient”

o “We put together a full marketing program for the retailers to help them be successful and it’s successful in driving store brand volume share”

“We continue to execute on our plan while expanding the breadth and reach of our product portfolio. We met or surpassed all of our originally stated adjusted financial goals for the fiscal year that were set last August on a continuing operations basis.”

In March 2012, Joseph Papa was named on Barron’s list of top CEOs. “Why: Puts safety first while cranking out drugs”.

On December 6, 2011. Perrigo Company Joined the NASDAQ-100 Index

Going Forward

“Really the growth driver is very much what I talked about before, growth in store brand, international, our Rx performance and clearly the new products will have about $190 million of new product revenue just this year, our fiscal year 2012, representing over 45 new products”.

“We think that over the next five years we think there are approximately over $10 billion to $15 billion products that are prescription items today that will move over-the-counter in the next five plus years. So we are really excited about what it means for the future for us”

Upload a collection of supporting files and web addresses to our server to provide more background information to the judges. You may upload any number of attachments and URLs through the "Add Attachments, Videos, or Links to This Entry" link above.

http://investing.businessweek.com/research/stocks/people/person.asp?personId=1339978&ticker=PRGO:US
http://seekingalpha.com/article/318427-perrigo-company-s-ceo-presents-at-the-30th-annual-j-p-morgan-healthcare-conference-transcript
http://www.reliableplant.com/Read/23582/Perrigo-acquires-formula-manufacturer
http://online.barrons.com/article/SB50001424053111904797004577281720885779812.html
http://perrigo.com/uploadedFiles/Investors/Presentations/120508%20FY12Q2%20Earnings%20Slides%20for%20upload%20FINAL%2002%2007%2012.pdf
http://www.biospace.com/news_story.aspx?StoryID=246215&full=1
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201203010910PR_NEWS_USPRX____DE62255&feedID=600&press_symbol=233561
http://www.theperrigo100.com/index.php/page/about
http://www.equities.co.il/Perrigo

Provide a brief (up to 100 words) biography about the nominee:

Mr. Papa joined Perrigo on October 9, 2006 as President and Chief Executive Officer and was elected a Director in November 2006 and Chairman of the Board in October 2007. He previously served as Chairman and Chief Executive Officer of the Pharmaceutical and Technologies Services segment of Cardinal Health. Prior to that position, he served as President and Chief Operating Officer of Watson Pharmaceuticals. Additionally, he has held management positions at DuPont Pharmaceuticals, Pharmacia Corporation, G. D. Searle and Novartis.